BRAF and Wilson disease: As BRAF alterations would represent a potentially targetable driver in WD panNET that may be sensitive to selective RAF and MEK inhibitors, in a disease without other targetable alterations, we queried the incidence and spectrum of BRAF alterations in a cohort of WD panNET sequenced at our institution.